The vasoactive intestinal peptide receptor on intact human colonic adenocarcinoma cells (HT29-D4). Evidence for its glycoprotein nature
- 15 February 1987
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 242 (1) , 185-191
- https://doi.org/10.1042/bj2420185
Abstract
We have previously shown that the mono [125I]iodinated vasoactive intestinal peptide (125I-VIP) could be covalently cross-linked on intact colonic adenocarcinoma cells (HT29). A major Mr 67,000 and a minor Mr 120,000 cross-linked polypeptides have been characterized [Muller, Luis, Fantini, Abadie, Giannellini, Marvaldi & Pichon (1985) Eur. J. Biochem. 151, 411-417]. The glycoprotein nature of these species was investigated using endo-beta-acetylglucosaminidase F (Endo F) treatment, enzymic and chemical desialylation and wheat germ agglutinin (WGA)-Sepharose affinity chromatography. Affinity-labelled VIP-binding proteins solubilized by Nonidet P-40 bound to WGA-Sepharose and could be eluted specifically with N-acetyl-D-glucosamine. Treatment with Endo F resulted in an increased electrophoretic mobility of both polypeptides. The major and the minor VIP-binding proteins were converted respectively into Mr 47,000 and 100,000 species, indicating removal of 20 kDa of N-linked oligosaccharides. Deglycosylation with trifluoromethanesulphonic acid also led to a 20 kDa loss in mass of the Mr 67,000 component, indicating the absence of additional O-linked sugars on this polypeptide. The presence of sialic acid on the major VIP-binding protein was demonstrated after treatment of intact cells with neuraminidase or by chemical desialylation with hydrochloric acid. We conclude from this study that the VIP receptor from intact HT29-D4 cells is a glycoprotein with N-linked oligosaccharide side chains containing sialic acid.Keywords
This publication has 29 references indexed in Scilit:
- Characterization of the vasoactive intestinal peptide (VIP) binding sites: A biochemical and an immunological approachPeptides, 1986
- Cycle of the vasoactive intestinal peptide and its binding site in a human adenocarcinoma cell line (HT 29)European Journal of Biochemistry, 1986
- Vasoactive intestinal peptide (VIP) receptor on liver plasma membranes: characterization as a glycoproteinBiochemistry, 1986
- Internalization of the vasoactive intestinal peptide (VIP) in a human adenocarcinoma cell line (HT29)European Journal of Biochemistry, 1985
- Covalent cross‐linking of vasoactive intestinal peptide (VIP) to its receptor in intact colonic adenocarcinoma cells in culture (HT 29)European Journal of Biochemistry, 1985
- Molecular identification of receptors for vasoactive intestinal peptide in rat intestinal epithelium by covalent cross‐linkingEuropean Journal of Biochemistry, 1984
- A new neuroregulator: The vasoactive intestinal peptide or VIPMolecular and Cellular Endocrinology, 1982
- Binding of human fibroblast interferon to concanavalin A-agarose. Involvement of carbohydrate recognition and hydrophobic interactionBiochemistry, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Preparation of Iodine-131 Labelled Human Growth Hormone of High Specific ActivityNature, 1962